世界の造影剤/コントラスト剤市場:種類別(ヨウ素化、ガドリニウム、バリウム、およびマイクロバブル)、処置別(X線/ CT、MRI、および超音波)、用途別(放射線学、インターベンショナル放射線学、インターベンショナル心臓学)、地域別

◆英語タイトル:Contrast Media/Contrast Agent Market by Type (Iodinated, Gadolinium, Barium, and Microbubble), Procedure (X-Ray/CT, MRI, and Ultrasound), Application (Radiology, Interventional Radiology, and Interventional Cardiology), Region - Global Forecast to 2024
◆商品コード:MD 3577
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2019年12月23日
◆ページ数:161
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥539,550見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥724,850見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥888,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

MarketsandMarkets社は、造影剤/コントラスト剤の世界市場規模が2019年50億ドルから2024年60億ドルまで年平均3.8%成長すると予測しています。本書は、世界の造影剤/コントラスト剤市場について調査・分析し、市場概要、種類別(標準プラスチック、エンジニアリングプラスチック、高性能プラスチック(HPP)、シリコン、その他)分析、用途別(医療用使い捨て品、補綴、医療器具&ツール、薬物送達、その他)分析、地域別分析、競合環境、企業概要などを掲載しております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の造影剤/コントラスト剤市場:種類別(ヨード造影剤、ガドリニウム系造影剤、マイクロバブル造影剤、バリウム系造影剤)
・世界の造影剤/コントラスト剤市場:モダリティ別(X-Ray / Ct、磁気共鳴イメージング、超音波)
・世界の造影剤/コントラスト剤市場:疾患別(心血管疾患、がん、胃腸障害、筋骨格障害、神経障害、腎障害)
・世界の造影剤/コントラスト剤市場:投与経路別(血管内経路、経口経路、直腸経路、その他)
・世界の造影剤/コントラスト剤市場:用途別(放射線科、介入放射線科、介入心臓科)
・世界の造影剤/コントラスト剤市場:地域別
・競合環境
・企業概要
・付録
【レポートの概要】

“Contrast media/contrast agents market is projected to grow at a CAGR of 3.8%.”
The global contrast media/contrast agents market is projected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period. The contrast media market has witnessed various advancements in products and their approvals to meet the needs of patients and radiologists worldwide.
Growth in the market can primarily be attributed to factors such as the increasing number of approvals for contrast agents and the rising volume of CT and MRI examinations globally. The growing number of research & funding activities for contrast agents and their applications provide immense opportunities for players in the contrast media market.

“The X-ray/CT procedures segment to hold the largest contrast media market share in 2019.”
Based on modality, the market is segmented into X-ray/CT, MRI, and ultrasound procedures. In 2019, X-ray/CT procedures segment is expected to command the largest share of the global contrast media market. The large share of this segment can be attributed to the increasing number of CT examinations across the globe, coupled with advancements in CT imaging technologies.

“The cardiovascular disorders segment is projected to grow at the highest CAGR during the forecast period.”
Based on the indication, the contrast media market is categorized into cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. The cardiovascular disorders segment is expected to grow at the highest CAGR during the forecast period. Improvements in cardiac MRI procedures in cath labs, favorable reimbursement policies for contrast media used in cardiovascular diagnosis, and strong healthcare infrastructure in developed countries are some of the factors driving this segment.

“Asia Pacific to witness the highest growth during the forecast period.”
Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2019–2024. Factors such as increasing R&D investments and favorable demographic scenario in China, rising aging population and cancer incidence in Japan, growing investments in the Indian radiology market, and growing focus of market players & increasing government support in other APAC countries are driving the growth of the contrast media market in this region.

Break of primary participants was as mentioned below:
 By Company Type: Tier I: 55%, Tier II: 25%, Tier III: 20%
 By Designation: C-Level Executives: 43%, Directors: 32%, Others: 25%
 By Region: North America: 38%, Europe: 23%, Asia Pacific : 29%, RoW: 10%
GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany),Guerbet (France), Lantheus (US) were the leading players in the contrast media market.

Research Coverage
This report studies the Contrast Media/Contrast Agents market based on product, application, modality, indication, route of administration and region. The report also studies the different factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the Contrast Media/Contrast Agents market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the contrast media market and garner greater market shares.

【レポートの目次】

1 Introduction (Page No. – 19)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders
2 Research Methodology (Page No. – 22)
2.1 Research Data
2.1.1 Secondary and Primary Research Methodology
2.1.1.1 Secondary Research
2.1.1.2 Primary Research
2.1.2 Key Insights From Primary Sources
2.1.3 Market Size Estimation Methodology
2.1.4 Revenue Mapping-Based Market Estimation
2.1.5 Market Data Validation and Triangulation
2.2 Assumptions
3 Executive Summary (Page No. – 32)
4 Premium Insights (Page No. – 37)
4.1 Contrast Media Market Overview
4.2 European Contrast Media Market, By Modality (2019)
4.3 Contrast Media Market Share, By Modality, 2019 vs. 2024
4.4 Contrast Media Market Share, By Route of Administration, 2019 vs. 2024
4.5 Contrast Media Market Share, By Indication, 2019 vs. 2024
4.6 Contrast Media Market Share, By Application, 2019 vs. 2024
4.7 Contrast Media Market Share, By Type, 2019 vs. 2024
4.8 Geographic Snapshot: Contrast Media Market
5 Market Overview (Page No. – 42)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Prevalence of Cancer and Cvds
5.2.1.2 Approvals of Contrast Agents
5.2.1.3 Increasing Demand for Early Diagnosis and Rising Volume of Ct and Mri Examinations
5.2.2 Restraints
5.2.2.1 Side-Effects and Allergic Reactions Associated With Contrast Agents
5.2.3 Opportunities
5.2.3.1 Generic Contrast Media
5.2.3.2 Increasing Research
5.2.4 Challenges
5.2.4.1 Technological Advancements in Imaging Solutions
5.2.4.2 Restriction and Withdrawal of Linear Gadolinium-Based Contrast Agents
6 Contrast Media/Contrast Agents Market, By Type (Page No. – 48)
6.1 Introduction
6.2 Iodinated Contrast Media
6.2.1 Extensive Usage of Iodinated Contrast Media in Ct Examinations is A Key Factor Supporting Market Growth
6.3 Gadolinium-Based Contrast Media
6.3.1 APAC is the Fastest-Growing Market for Gadolinium-Based Contrast Media
6.4 Microbubble Contrast Media
6.4.1 Microbubble Contrast Media to Register the Highest Growth Rate During the Forecast Period
6.5 Barium-Based Contrast Media
6.5.1 Barium-Based Contrast Media Can Cause Adverse Effects in Patients, Owing to Which the Market is Projected to Decline
7 Contrast Media/Contrast Agents Market, By Modality (Page No. – 53)
7.1 Introduction
7.2 X-Ray/Ct
7.2.1 X-Ray/Ct Accounts For The Largest Share of the Contrast Media Market
7.3 Magnetic Resonance Imaging
7.3.1 Growing Number of Mri Scanners and Increasing Mri Examinations are Likely to Drive Market Growth
7.4 Ultrasound
7.4.1 Ultrasound Contrast Agents Will Register the Highest Growth Rate During the Forecast Period
8 Contrast Media/Contrast Agents Market, By Indication (Page No. – 59)
8.1 Introduction
8.2 Cardiovascular Diseases
8.2.1 Cardiovascular Diseases Segment to Dominate the Contrast Media Market
8.3 Cancer
8.3.1 Asia Pacific is Expected to Register Relatively Higher Growth Owing to the High Cancer Prevalence in the Region
8.4 Gastrointestinal Disorders
8.4.1 Rising Prevalence of Gi Disorders to Support Market Growth
8.5 Musculoskeletal Disorders
8.5.1 Rising Incidence of Work-Related Musculoskeletal Disorders to Support Market Growth
8.6 Neurological Disorders
8.6.1 Rising Prevalence of Dementia Worldwide to Support Market Growth
8.7 Nephrological Disorders
8.7.1 Rising Prevalence of Esrd is Driving the Demand for Diagnostic Tools for Kidney Diseases
9 Contrast Media/Contrast Agents Market, By Route of Administration (Page No. – 66)
9.1 Introduction
9.2 Intravascular Route
9.2.1 Intravascular Route of Administration is Expected to Grow at the Highest CAGR During the Forecast Period
9.2.1.1 Intravenous (IV)
9.2.1.2 Intra-Arterial (IA)
9.3 Oral Route
9.3.1 North America to Dominate the Contrast Media Market for Oral Route of Administration
9.4 Rectal Route
9.4.1 Contrast Agents Administered Rectally are Liquid E-Z-Paque, Liquid Polibar Plus, and Micropaque
9.5 Other Routes of Administration
10 Contrast Media/Contrast Agents Market, By Application (Page No. – 71)
10.1 Introduction
10.2 Radiology
10.2.1 Growing Number of Diagnostic Procedures to Drive the Contrast Media Market for Radiology Applications
10.3 Interventional Radiology
10.3.1 Increasing Popularity of Minimally Invasive Procedures to Support Market Growth
10.4 Interventional Cardiology
10.4.1 Rising Incidence of Cardiac Disorders to Drive the Demand for Interventional Cardiology Procedures
11 Contrast Media/Contrast Agents Market, By Region (Page No. – 76)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.1.1 The US Dominates the Global Contrast Media Market
11.2.2 Canada
11.2.2.1 Increasing Investments in Improving Medical Imaging—A Major Factor Driving Market Growth in Canada
11.3 Europe
11.3.1 Germany
11.3.1.1 Presence of A Well-Developed Diagnostic Imaging Infrastructure is A Major Factor Supporting Market Growth in Germany
11.3.2 France
11.3.2.1 Increasing Prevalence of Cancer Will Drive the Market for Contrast Media in France
11.3.3.1 Increasing Investments in the Field of Diagnostic Imaging to Boost Market Growth
11.3.4 Italy
11.3.4.1 Growing Prevalence of Cancer and Obesity Will Drive the Demand for Diagnostic Procedures in Italy
11.3.5 Spain
11.3.5.1 Shortage of Radiologists in the Country to Restrain Market Growth
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.1.1 Japan Dominates the APAC Contrast Media Market
11.4.2 China
11.4.2.1 High Incidence of Cancer and Strokes Will Support the Market for Contrast Media in China
11.4.3 India
11.4.3.1 Growing Investments in the Indian Radiology Market Will Propel Market Growth
11.4.4 Rest of Asia Pacific
11.5 Rest of the World
12 Competitive Landscape (Page No. – 115)
12.1 Introduction
12.2 Market Share Analysis
12.3 Right-To-Win
12.4 Competitive Leadership Mapping
12.4.1 Visionary Leaders
12.4.2 Innovators
12.4.3 Dynamic Differentiators
12.4.4 Emerging Companies
12.5 Competitive Scenario
12.5.1 Product Launches & Approvals
12.5.2 Expansions
12.5.3 Acquisitions
12.5.4 Partnerships & Agreements
13 Company Profiles (Page No. – 123)
(Business Overview, Products Offered, Recent Developments, and Mnm View)*
13.1 GE Healthcare
13.2 Bracco Imaging S.P.A
13.3 Bayer AG
13.4 Guerbet Group
13.5 Lantheus Medical Imaging, Inc.
13.6 Daiichi Sankyo
13.7 Unijules Life Sciences
13.8 J.B. Chemicals and Pharmaceuticals Ltd.
13.9 Sanochemia
13.10 Magnus Health
13.11 Taejoon Pharm
13.12 Jodas Expoim
13.13 Nano Therapeutics Pvt. Ltd.
13.14 Kiran X-Ray
13.15 Interpharma Praha A.S.
13.16 Imax Diagnostic Imaging Limited
13.17 Yangtze River Pharmaceutical Group (YRPG)
13.18 Spago Nanomedical AB
13.19 Subhra Pharma Pvt. Ltd.
13.20 M. Biotech Limited
13.21 Mri Contrast Agents: Product Comparison
13.22 CT Contrast Agents: Product Comparison
13.23 Ultrasound Contrast Agents: Product Comparison
*Details on Business Overview, Products Offered, Recent Developments, and Mnm View Might Not Be Captured in Case of Unlisted Companies.
14 Appendix (Page No. – 157)
14.1 Discussion Guide
14.2 Available Customizations
14.3 Related Reports
14.4 Author Details

List of Tables (121 Tables)
Table 1 List of Side-Effects/Reactions to Contrast Media, By Type
Table 2 Indicative List of Research Studies
Table 3 Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 4 Iodinated Contrast Media Market, By Region, 2017–2024 (USD Million)
Table 5 Gadolinium-Based Contrast Media Market, By Region, 2017–2024 (USD Million)
Table 6 Microbubble Contrast Media Market, By Region, 2017–2024 (USD Million)
Table 7 Barium-Based Contrast Media Market, By Region, 2017–2024 (USD Million)
Table 8 Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 9 Installed Base of CT Scanners, By Region, 2017 vs. 2018
Table 10 Increase in CT Procedural Volumes, By Region, 2017 vs. 2018 (Million)
Table 11 X-Ray/CT Contrast Media Market, By Region, 2017–2024 (USD Million)
Table 12 Installed Base of Mri Systems, By Region, 2017 vs. 2018
Table 13 Increase in Mri Procedural Volumes, By Region, 2017 vs. 2018 (Million)
Table 14 Mri Contrast Media Market, By Region, 2017–2024 (USD Million)
Table 15 Ultrasound Contrast Media Market, By Region, 2017–2024 (USD Million)
Table 16 Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 17 Contrast Media Market for Cardiovascular Diseases, By Region, 2017–2024 (USD Million)
Table 18 Contrast Media Market for Cancer, By Region, 2017–2024 (USD Million)
Table 19 Contrast Media Market for Gastrointestinal Disorders, By Region, 2017–2024 (USD Million)
Table 20 Contrast Media Market for Musculoskeletal Disorders,By Region, 2017–2024 (USD Million)
Table 21 Contrast Media Market for Neurological Disorders, By Region, 2017–2024 (USD Million)
Table 22 Contrast Media Market for Nephrological Disorders, By Region, 2017–2024 (USD Million)
Table 23 Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 24 Contrast Media Market for Intravascular Route of Administration, By Region, 2017–2024 (USD Million)
Table 25 Contrast Media Market for Oral Route of Administration, By Region, 2017–2024 (USD Million)
Table 26 Contrast Media Market for Rectal Route of Administration, By Region, 2017–2024 (USD Million)
Table 27 Contrast Media Market for Other Routes of Administration, By Region, 2017–2024 (USD Million)
Table 28 Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 29 Contrast Media Market for Radiology Applications, By Region,2017–2024 (USD Million)
Table 30 Contrast Media Market for Interventional Radiology Applications, By Region, 2017–2024 (USD Million)
Table 31 Contrast Media Market for Interventional Cardiology Applications, By Region, 2017–2024 (USD Million)
Table 32 Contrast-Enhanced CT Procedural Volume, By Region, 2017 vs. 2018 (Million)
Table 33 Contrast-Enhanced Mri Procedural Volume, By Region, 2017 vs. 2018 (Million)
Table 34 Contrast Media Market, By Region, 2017–2024 (USD Million)
Table 35 North America: Contrast Media Market, By Country, 2017–2024 (USD Million)
Table 36 North America: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 37 North America: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 38 North America: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 39 North America: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 40 North America: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 41 US: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 42 US: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 43 US: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 44 US: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 45 US: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 46 Canada: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 47 Canada: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 48 Canada: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 49 Canada: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 50 Canada: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 51 Europe: Contrast Media Market, By Country, 2017–2024 (USD Million)
Table 52 Europe: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 53 Europe: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 54 Europe: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 55 Europe: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 56 Europe: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 57 Germany: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 58 Germany: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 59 Germany: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 60 Germany: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 61 Germany: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 62 France: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 63 France: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 64 France: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 65 France: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 66 France: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 67 UK: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 68 UK: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 69 UK: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 70 UK: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 71 UK: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 72 Italy: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 73 Italy: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 74 Italy: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 75 Italy: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 76 Italy: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 77 Spain: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 78 Spain: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 79 Spain: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 80 Spain: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 81 Spain: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 82 RoE: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 83 RoE: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 84 RoE: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 85 RoE: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 86 RoE: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 87 APAC: Contrast Media Market, By Country, 2017–2024 (USD Million)
Table 88 APAC: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 89 APAC: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 90 APAC: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 91 APAC: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 92 APAC: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 93 Japan: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 94 Japan: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 95 Japan: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 96 Japan: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 97 Japan: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 98 China: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 99 China: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 100 China: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 101 China: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 102 China: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 103 India: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 104 India: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 105 India: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 106 India: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 107 India: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 108 RoAPAC: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 109 RoAPAC: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 110 RoAPAC: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 111 RoAPAC: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 112 RoAPAC: Contrast Media Market, By Application,2017–2024 (USD Million)
Table 113 RoW: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 114 RoW: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 115 RoW: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 116 RoW: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 117 RoW: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 118 Product Launches & Approvals (2016–2019)
Table 119 Expansions (2016–2019)
Table 120 Acquisitions (2016–2019)
Table 121 Partnerships & Agreements (2016–2019)

List of Figures (36 Figures)
Figure 1 Research Methodology Steps: Contrast Media Market
Figure 2 Research Design
Figure 3 Key Data From Secondary Sources
Figure 4 Breakdown of Primary Interviews: By Company Type,Designation, and Region
Figure 5 Key Data From Primary Sources
Figure 6 Research Methodology: Hypothesis Building
Figure 7 Data Triangulation Methodology
Figure 8 Contrast Media Market, By Modality, 2019 vs. 2024 (USD Million)
Figure 9 Contrast Media Market, By Route of Administration, 2019 vs. 2024 (USD Million)
Figure 10 Contrast Media Market, By Indication, 2019 vs. 2024 (USD Million)
Figure 11 Contrast Media Market, By Application, 2019 vs. 2024 (USD Million)
Figure 12 Contrast Media Market, By Type, 2019 vs. 2024 (USD Million)
Figure 13 Asia Pacific is Slated to Witness the Highest Growth in the Contrast Media Market During the Forecast Period
Figure 14 Growing Volume of CT and Mri Examinations Will Drive the Growth of the Contrast Media Market
Figure 15 Germany Accounts for the Largest Share of the Contrast Media Market in Europe
Figure 16 X-Ray/CT Will Continue to Dominate the Contrast Media Market, By Modality, in 2024
Figure 17 Intravascular Route Accounts for the Largest Share of the Market
Figure 18 Cardiovascular Diseases to Account for the Largest Share of the Contrast Media Market in 2024
Figure 19 Radiology Commands the Largest Share of the Contrast Media Market
Figure 20 Iodinated Contrast Media Account for the Largest Share of the Contrast Media Market, By Type
Figure 21 APAC to Witness Highest Growth During the Forecast Period
Figure 22 Contrast Media Market: Drivers, Restraints, Opportunities, and Challenges
Figure 23 North America Will Continue to Dominate the Contrast Media Market in 2024
Figure 24 North America: Contrast Media Market Snapshot
Figure 25 Asia Pacific: Contrast Media Market Snapshot
Figure 26 Key Developments in the Contrast Media Market, 2016–2019
Figure 27 Contrast Media Market Share, By Key Player, 2018
Figure 28 Contrast Media Market: Competitive Leadership Mapping, 2018
Figure 29 GE Healthcare: Company Snapshot (2018)
Figure 30 Bracco Imaging S.P.A: Company Snapshot (2018)
Figure 31 Bayer Ag: Company Snapshot (2018)
Figure 32 Guerbet Group: Company Snapshot (2018)
Figure 33 Lantheus: Company Snapshot (2018)
Figure 34 Daiichi Sankyo: Company Snapshot (2018)
Figure 35 J.B. Chemicals & Pharmaceuticals: Company Snapshot (2018)
Figure 36 Sanochemia: Company Snapshot (2018)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の造影剤/コントラスト剤市場:種類別(ヨウ素化、ガドリニウム、バリウム、およびマイクロバブル)、処置別(X線/ CT、MRI、および超音波)、用途別(放射線学、インターベンショナル放射線学、インターベンショナル心臓学)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆